Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
2 minute read

5 Stocks Insiders Are Selling

By Lisa Levin
Today, 2:35 AM
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.

EAT

Read More
2 minute read

Seagen Late Sunday Announced Prelim. Results From Phase 2 Trial Of ADCETRIS In Novel Combo Of Agents For Patients With Advanced Stage Classical Hodgkin Lymphoma: Showed ‘Complete Response Rate of 88%, Overall Response Rate of 93%’

By Benzinga Newsdesk
Today, 2:35 AM
– Frontline Treatment with ADCETRIS in Combination with Nivolumab, Doxorubicin and Dacarbazine (AN+AD) Shows a Complete Response Rate of 88%, Overall Response Rate of 93% and Favorable Safety Profile

SGEN

Read More
2 minute read

5 Stocks Insiders Are Selling

By Lisa Levin
Today, 2:35 AM
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.

ANET

Read More
1 minute read

Where Seagen Stands With Analysts

By Benzinga Insights
Today, 2:35 AM
Over the past 3 months, 6 analysts have published their opinion on Seagen (NASDAQ:SGEN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

SGEN